Tuesday , November 19 2019
Home / argentina / Chile will give tablets to prevent HIV spread NEW | Industry

Chile will give tablets to prevent HIV spread NEW | Industry



The Chilean Government announced on Friday free delivery of pre-exposure prophylaxis tablets (PrEP)A doctor that prevents HIV transmission; throughout First quarter of 2019

To this end, the Chilean authorities have duplicated the number of people infected by the virus over the last seven years, Homosexual integration and liberation movement (Movilh), Next year, with the aim of defining the protocols that regulate its use.

"PrEP can reduce the chance of buying a virus with more than 90% in sexual practice if taken every day. For this reason, it helps to promote the protocol that drives the people of its own realities and safe sexual practices, as it causes relaxation of the pill, "said Diego Ríos Movilh Health Director.

According to the Health Ministry, Emilio Santelices, The PrEP pill is part of a new AIDS and HIV prevention plan that will be applied as a preventive treatment in high-risk populations.

How does it work?

According to the United States Department of Disease Control and Prevention Centers (CDC), if you get PrEP every day, you will get Reduced by more than 90% The possibility of hiring a sexually transmitted AIDS person is the use of sterilized or used people with a population of 70% or more.

It has PrEP emtricitabine and tenofovirTwo viruses are also used to reduce the number of drugs used in both antiretrovirals and do not multiply.

The tablets are not working as a vaccine because antibodies do not cause them, but because they are necessary for daily intake, emtricitabine and tenofovir appear in the bloodstream to prevent it from being placed in the liver and at the liver.

Before the illness, it is necessary to check the condition of the kidneys and liver, because this pill can cause the disorders of these organs.

More information

In 2012, Gilead Sciences was a pharmaceutical company that started marketing this medicine under the brand name Truvada. According to the estimations, the commercial treatment value is about 600 dollars.

A few years later, the World Health Organization (WHO) began recommending the use of HIV prevention among high risk groups, such as sex workers or infected patients.

Data

According to Onusida data for 2016, 67,000 people in Chile are infected with HIV, of which 39,001 are treated; The projections increase this year by 100,000 affiliates.


Source link